4.3 Article

Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma

期刊

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
卷 22, 期 3, 页码 585-592

出版社

SPRINGER JAPAN KK
DOI: 10.1007/s10147-017-1100-7

关键词

Non-Hodgkin Lymphoma; B cell; Plasma DNA; p16; shp1; Methylation

类别

资金

  1. Tianjin cancer research programs of major projects foundation [12ZCDZSY18000]
  2. National Natural Science Foundation of China [81570106, 81570111, 81500101, 81600093, 81600088]
  3. Tianjin Municipal Natural Science Foundation [14JCYBJC25400, 15JCYBJC24300]
  4. Tianjin Health and Family Planning Commision [15KG150]

向作者/读者索取更多资源

Background Early diagnosis and treatment of non-Hodgkin lymphoma (NHL) are progressively important. It has been shown that aberrant promoter methylation contributes to the development and progression of lymphoma. We tried to explore the effect of methylation of p16 and shp1 genes in plasma in the diagnosis of B-NHL patients. Methods The methylation of p16 and shp1 genes in plasma were detected by methylation specific polymerase chain reaction in 103 patients with B-NHL, and compared with peripheral blood leukocytes (PBLs) and formaldehydefixed paraffin-embedded (FFPE) tumor tissues. Results The results showed that methylation frequency of p16 in plasma, PBLs, and FFPE tumor tissues of newly diagnosed B-NHL patients were 37% (27/73), 16% (12/73) and 39% (16/41), whereas those of shp1 were 47% (34/73), 25% (18/73) and 63% (26/41). High methylation consistency of p16/shp1 between plasma and FFPE tumor tissues were revealed (the values of kappa: 0.84, 0.80). Moreover, there were a higher frequency of methylated p16 in all three samples in patients with B symptoms and lower platelet count (< 100 x 10(9)/L), as well as in patients with stage III/ IV in plasma and FFPE tumor tissues. Meanwhile, higher frequency of methylated shp1 was observed in patients with higher LDH level in all three samples. Conclusion Methylation of p16/shp1 in plasma can represent their methylation status in tumor tissues, and may be promising biomarkers in early diagnosis and prognosis evaluation in B-NHL.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据